Abiopharma

🔍 Briggs Teresa (Director)

Company: Warby Parker Inc. (WRBY)

Report Date: 2026-06-16

Detailed Transactions and Holdings:

• Sold 3,092 shares of Class A Common Stock at $25.41 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 50,791.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,908 shares of Class A Common Stock at $26.79 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 48,883.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-06-16 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 15,969.00 | Footnotes: F4

Footnotes:

• F1: These share sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2026.
• F2: The price reported in Column 4 is an average execution price rounded to the nearest hundredth. These shares were sold in multiple transactions at prices ranging from $25.05 to $25.82 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
• F3: The price reported in Column 4 is an average execution price rounded to the nearest hundredth. These shares were sold in multiple transactions at prices ranging from $26.46 to $27.06 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
• F4: Ms. Briggs may be deemed to have voting power and dispositive power over the shares held by The Teresa Briggs Trust.